Health News
Voluntary Recall of Soliris
Alexion Pharmaceuticals, Inc. announced that it is initiating a voluntary recall of certain lots of Soliris (eculizumab) 300mg/30 mL concentrated solution for intravenous infusion.
Mega-Dose of Measles Vaccine Killed Cancer
Multiple myeloma is a cancer that develops in the bone marrow and is considered by many to be incurable. An engineered measles virus, however, may change that.
FDA Compares Risks of Pradaxa and Warfarin
FDA research has taken a closer look at the risks of two medications commonly used to lower the risk for stroke and blood clots.
FDA Approves Sylvant for Rare Castleman’s Disease
The U.S. Food and Drug Administration today approved Sylvant (siltuximab) to treat patients with multicentric Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the lymph nodes).
FDA Approves New Leukemia Treatment
The FDA has given some leukemia patients a new treatment option.
Why Childhood Cancer Survival Rates Have Increased
With increasing survival rates for many types of childhood cancers, some of these cancers are approaching cures. Several key events have made this possible.
FDA Approves Pradaxa for Clotting Disorders
US regulators have approved a medication to treat and reduce two dangerous clotting disorders.
FDA Approves Alprolix for Patients With Hemophilia B
The U.S. Food and Drug Administration today approved Alprolix, Coagulation Factor IX (Recombinant), Fc Fusion Protein, for use in adults and children who have Hemophilia B. Alprolix is the first Hemophilia B treatment designed to require less frequent injections when used to prevent or reduce the frequency of bleeding.
Traffic May be Deadly, But Not the Way You’d Expect
Many people consider living near traffic to be dangerous for children, fearing accidents. New research suggests that traffic can be harmful to children for other reasons.
Rare Diseases You've Never Heard Of
In an effort to help raise awareness about rare diseases, here is an introduction to several rare conditions you might not know existed.